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Allergic response to environmental allergens 
is a common health problem. It is still unclear 
how allergens trigger the innate immune system, 
which in turn induces long-lasting type 2 adap-
tive responses. Epithelial cells, as the fi  rst cell type 
encountering allergens, have been shown to ini-
tiate tissue infl  ammatory responses by producing 
various cytokines and chemokines, which may 
create a permissive environment for the recruit-
ment of infl  ammatory cells and amplifi  cation of 
allergic responses. CD4+ Th cells are essential 
regulators in chronic allergic diseases. Upon 
activation, Th cells undergo diff  erentiation into 
functionally distinct eff  ector subsets. Th1 cells 
produce IFN-γ and regulate cellular immu-
nity, whereas Th2 cells produce IL-4, IL-5, and 
IL-13 and mediate humoral immunity and 
allergic responses (1, 2). A novel Th cell subset 
expressing IL-17 regulates tissue infl  ammatory 
responses (3). During Th2 cell diff  erentiation, 
in which GATA-3 serves as a master transcrip-
tion factor (2), IL-4 produced by activated Th 
cells is essential for driving Th2 cell diff  erentia-
tion (1). NFATc1 and JunB have been shown 
to be important in regulating early IL-4 produc-
tion and in determining Th2 cell diff  erentiation 
(4). The terminal diff  erentiation of Th cells is 
determined by the innate immune system and 
the cytokines it produces. Despite the molecular 
understanding of the Th2 cell regulatory pro-
grams, whether there is a signal induced during 
the innate response to allergens that augments 
IL-4 expression by T cells and regulates Th2 cell 
diff  erentiation remains unclear.
IL-25 (also known as IL-17E), a member of 
the IL-17 family, has been implicated in Th2 
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The molecular mechanisms underlying the initiation of innate and adaptive proallergic type 2 
responses are not understood. Interleukin (IL) 25, a member of the IL-17 cytokine family, 
was recently reported (Owyang, A.M., C. Zaph, E.H. Wilson, K.J. Guild, T. McClanahan, 
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to be important in Th2 cell–mediated immunity to parasitic infection. However, the cellular 
source and targets of IL-25 are not well understood. We show that mouse IL-25 is 
expressed by lung epithelial cells as a result of innate immune responses to allergens. 
Transgenic overexpression of IL-25 by these cells leads to mucus production and airway 
infi  ltration of macrophages and eosinophils, whereas blockade of IL-25 conversely reduces 
the airway infl  ammation and Th2 cytokine production in an allergen-induced asthma 
model. In addition, IL-25, with a receptor more highly expressed in Th2 than other effector 
T cells, promotes Th2 cell differentiation in an IL-4– and signal transducer and activator of 
transcription 6–dependent manner. During early T cell activation, IL-25 potentiates expres-
sion of the nuclear factor of activated T cells c1 and JunB transcription factors, which 
possibly results in increased levels of initial IL-4 production, up-regulation of GATA-3 
expression, and enhanced Th2 cell differentiation. Thus, IL-25 is a critical factor regulating 
the initiation of innate and adaptive proallergic responses.
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cell–mediated immunity (5, 6). IL-25 shares a receptor, 
named IL-17RB, with IL-17B, although it binds with much 
higher affi   nity than IL-17B (7). IL-17RB mRNA transcripts 
are abundantly expressed in the kidney and liver and at lower 
levels in the testes, brain, small intestine, and other organs (7). 
Overexpression of IL-25 or administration of recombinant 
cytokine strongly induced Th2 cytokine expression and IgE 
production in vivo and resulted in allergic pathologies (5, 6, 
8, 9). Conversely, mice defi  cient in IL-25 exhibited reduced 
Th2 cytokine production in the draining lymph nodes, re-
sulting in poor resistance to Trichuris infection (10, 11). The 
molecular mechanisms whereby IL-25 regulates type 2 im-
munity are still unclear. A non–B/T cell population was found 
to be regulated by IL-25 and produce Th2 cytokines in re-
sponse to Nippostrongylus brasiliensis infection (11). However, 
given the broad expression of IL-17RB, additional targets of 
IL-25 may exist to regulate allergic responses.
In this report, we found that IL-25 mRNA was up-regu-
lated in epithelial cells after allergen stimulation. Chronic over-
expression of IL-25 in airway epithelium resulted in asthma 
symptoms, whereas blockade of IL-25 attenuated allergen-
induced lung infl  ammation and Th2 cytokine expression. 
Moreover, we found that IL-25 directly promoted Th2 cell dif-
ferentiation and GATA-3 expression in an IL-4– and STAT6-
dependent manner. IL-25 enhanced NFATc1 and JunB 
expression to potentiate early IL-4 expression and the expan-
sion and cytokine production of eff  ector Th2 cells.
RESULTS AND D  I  S  C  U  S  S  I  O  N 
Expression of IL-25 by lung epithelial cells initiates 
allergic responses
In an attempt to defi  ne the initial innate mechanism in 
response to allergens, we treated a mouse lung epithelial 
cell line, MLE12, with the allergens Aspergillus oryzae and 
ragweed and characterized gene expression changes by 
RT-PCR. In addition to several chemokine genes (not 
  depicted), we found that IL-25 mRNA was substantially in-
duced in response to the allergens (Fig. 1 A). The expression 
of IL-25 by lung epithelial cells was further confi  rmed using 
a human lung epithelial cell line, A549, and primary type II 
alveolar epithelial cells isolated from C57BL/6 mice (Fig. 1 A). 
Our data are consistent with a previous observation of up-
regulation of IL-25 mRNA in lung tissue in response to 
A. fumigatus infection (5), suggesting that IL-25 induction in 
lung epithelial cells may play a role in initiating a type II 
immune response to allergens.
To address the function of IL-25 produced by lung epi-
thelial cells in vivo, we generated transgenic mice that over-
express IL-25 in lung epithelium using the CC10 promoter. 
Four founder lines were generated, of which two expressed 
high levels of IL-25 mRNA in the lung tissue and were se-
lected for histological analysis. Transgenic mice exhibited 
greatly increased levels of IL-25 mRNA expression in their 
lung tissues and protein in the bronchoalveolar lavage (BAL) 
fl  uid (Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20061675/DC1). Compared with littermate controls, 
IL-25 transgenic mice exhibited epithelial cell hyperplasia 
at 3 mo of age; after 3 mo of age, we observed goblet cell 
hyperplasia, epithelial cell hyperplasia, and infi  ltration of 
moderate numbers of eosin-stained enlarged macrophages 
and considerable numbers of eosinophils in the lung paren-
chyma (Fig. 1 B). Similar macrophage infi  ltration was found 
in cc10–IL-17 (12) and cc10–IL-17F (unpublished data) mice, 
whereas eosinophils were only seen in cc10–IL-25 mice. 
However, cc10–IL-13 transgenic mice were also found to 
have lung infi  ltration by macrophages and eosinophils (13). 
By performing periodic acid Schiff   (PAS) staining, mucus-
producing cells were found only in IL-25 transgenic mice 
and not in the control littermates (Fig. 1 B). In older IL-25 
transgenic mice between 7 and 10 mo of age, substantial in-
fi  ltration of CD4+ T cells and CD11C+ dendritic cells were 
found around blood vessels (unpublished data). IL-25 over-
production in lung epithelium thus led to allergic infl  amma-
tion in the lung.
To further investigate the regulation of allergic responses 
by IL-25, we examined cytokine and chemokine expression 
profi  les in lung tissues of IL-25 transgenic mice and their lit-
termate controls. The expression of eotaxin1 (Ccl11), eotaxin2 
(Ccl24), and MDC (Ccl22), which play crucial roles in the 
recruitment of eosinophil and Th2 cells, respectively, were 
detected in IL-25 transgenic mice (Fig. 1 C). Interestingly, 
mRNA for MUC5ac, the protein product of which consti-
tutes a major component of respiratory lining fl  uid, was 
elevated in IL-25 transgenic mice, correlating with mucus 
hypersecretion in the airways of these mice. To determine 
whether these chemokines and mucin are direct targets of 
IL-25, the MLE12 cell line was treated with IL-25, and the 
resulting gene expression changes were determined. Expres-
sion of chemokines relevant to eosinophil (eotaxin1) and Th2 
cell (regulated on activation, normal T cell expressed and se-
creted/CCL5 and MDC) recruitment, as well as MUC5ac, 
was strongly induced by IL-25 (Fig. 1 D). In addition, we 
also observed up-regulation of TSLP, which was recently 
established as a key factor in allergic infl  ammation (14). Col-
lectively, these data indicate that IL-25 induced by allergens 
in epithelial cells can function to initiate allergic responses.
To further examine the role of IL-25 during immune re-
sponses to allergens, a panel of rat anti–mouse IL-25 mAbs 
was generated and screened for its abilities to inhibit the 
binding of IL-25 to 293 cells transfected with IL-17RB. 
One clone (35B) was identifi  ed as an antagonistic antibody 
(unpublished data), which was used in an allergen-induced 
experimental asthma model. C57BL/6 mice were intranasally 
sensitized with allergens derived from A. oryzae together 
with chicken OVA protein every other day for a total of six 
challenges, as previously described (15). The airway pathol-
ogy developed in this model was previously found to be de-
pendent on IL-4 (16). Anti–IL-25 antibody or a control rat 
IgG was intraperitoneally administered at the time of each 
challenge. 24 h after the last allergen administration, the BAL 
and lungs were collected. In BAL fl  uid, the presence of in-
fl  ammatory cells was assessed by diff  erential cell counting and JEM VOL. 204, July 9, 2007  1511
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fl  ow cytometry analysis, and the levels of cytokine produc-
tion were determined by ELISA. Compared with mice 
treated with a control rat antibody, anti–IL-25 substantially 
reduced the number of eosinophils, an important indicator of 
airway infl  ammation; the infi  ltration of CD4+ T cells was 
moderately reduced (Fig. 1 E). Although the production of 
IFN-γ in BAL was moderately increased and TNF-α was 
not aff  ected, Th2 cytokines (IL-4, IL-5, and IL-13) were all 
signifi  cantly reduced by anti–IL-25 treatment (Fig. 1 F), in-
dicating that the IL-25 blockade may attenuate allergic airway 
infl  ammation through the reduction of the Th2 response. 
However, we observed no change in the goblet cell hyper-
plasia by anti–IL-25 treatment, suggesting that the remaining 
cytokines or other factors were suffi   cient in this regulation. 
For example, IL-13 has been previously indicated as an im-
portant cytokine with a distinct role from IL-4 in regulating 
the development of allergic asthma symptoms, including 
airway hyperesponsiveness, goblet cell hyperplasia, tissue 
remodeling, and fi  brosis (17). To further investigate the role of 
IL-25 in regulating T cell function during allergic responses, 
we restimulated splenocytes from the described experiment 
ex vivo with OVA protein for 3 d and measured their cyto-
kine production. Similar to the BAL data, antigen-specifi  c 
Th2 responses in cells from anti–IL-25–treated mice were 
reduced, especially the production of IL-5 and IL-13, whereas 
no alteration in the levels of IFN-γ and TNF-α was ob-
served (unpublished data). Our data suggest that IL-25 regu-
lates Th2 cell function during allergic responses. This result 
is consistent with recent studies on the important function of 
IL-25 in mediating antiparasitic immune responses (10, 11) 
and in airway infl  ammation (18), suggesting that allergens 
and large parasites may use a common pathway in activation 
of Th2 responses.
IL-25 promotes Th2 cell differentiation in vitro
The inhibitory eff  ect by anti–IL-25 or IL-25 gene deletion 
on Th2 responses in vivo suggests a role, direct or indirect, of 
IL-25 in Th2 cell diff  erentiation. Recently, high-level ex-
pression of IL-17RB by in vitro–derived Th2 cells and circu-
lating human Th2 cell–biased memory cells in vivo has been 
Figure 1.  IL-25 is expressed by lung epithelial cells and regulates 
allergic responses. (A) MLE12 cells, A549 cells, and primary type II alveolar 
epithelial cells stimulated with the indicated stimuli were analyzed by RT-
PCR for IL-25 mRNA expression after normalization with HPRT expression. 
(B) Histological analysis of lung tissues from 3-mo-old IL-25 transgenic 
mice (b) stained with H&E was compared with that from control littermate 
mice (a). Bars, 500 μm. Macrophages (AM) and eosinophils (Eo) infi  ltrated 
in the airway were demonstrated by H&E and Giemsa staining (c), and 
mucus hyperplasia stained with PAS in 5-mo-old IL-25 transgenic-positive 
mice are shown (d). Bars: (c) 50 μm; (d) 200 μm. (C) RT-PCR analysis of 
gene expression in 3-mo-old IL-25 transgenic mice was compared with 
littermate controls. (D) MLE12 cells treated for 6 h with IL-25 were 
subject to RT-PCR analysis in comparison with the nontreated cells. 
(E and F) C57BL/6 mice (4–5 mice in each group) were intranasally challenged 
with A. oryzae allergen and OVA every other day for a total of six challenges. 
An anti–IL-25 mAb or control rat Ig was intraperitoneally administered at the 
time of each challenge. 24 h after the fi  nal challenging, mice were killed, 
and BAL cells were collected and analyzed for the absolute numbers of 
eosinophils and CD4+ T cells by total cell counting, differential cell counts, 
and fl  ow cytometry analysis with mAbs to CCR3 (for eosinophils) and CD4 
(BD Biosciences). BAL fl  uid was examined for cytokine expression by ELISA. 
Horizontal bars in E represent the means. Data are presented as mean 
values + SD and are representative of two independent experiments. 
HPRT, hypoxanthine-guanine phosphoribosyltransferase. *, P < 0.05.1512  IL-25 REGULATION OF ALLERGIC RESPONSES | Angkasekwinai et al. 
previously reported (19–21), suggesting a possible function of 
IL-25 on T cells. To further investigate this idea, we fi  rst 
examined expression of the IL-25 receptor IL-17RB on 
diff  erent mouse Th cell populations. IL-17RB expression 
was detected on freshly isolated naive CD4+ T cells. After 
in vitro diff  erentiation, Th2 but not Th1 cells maintained this 
expression (Fig. 2 A). Moreover, IL-17RB expression was 
not detected in in vitro–generated IL-17–producing Th cells 
(unpublished data), indicating that IL-17RB expression is 
restricted to Th2 cells among three eff  ector Th cell subsets.
The selective expression of IL-17RB suggests that IL-25 
may play a role in regulating Th2 cell diff  erentiation. To assess 
this, CD44loCD62Lhi naive CD4+ T cells from C57BL/6 mice 
were cultured with anti-CD3, anti-CD28, and IL-2 in the 
presence or absence of IL-25. 4 d later, diff  erentiated cells were 
restimulated with anti-CD3, and cytokine expression was ex-
amined by ELISA. Although T cells activated in the absence 
of IL-25 predominately diff  erentiated into IFN-γ–producing 
Th1 cells, IL-25 treatment led to greatly increased levels of IL-4, 
IL-5, and IL-13 expression and moderately reduced amounts 
of IFN-γ expression by eff  ector T cells (Fig. 2 B). By intracel-
lular cytokine staining, we found that IL-25 treatment resulted 
in substantially increased numbers of IL-4–producing Th2 
cells, which was more pronounced when IFN-γ was neutral-
ized (Fig. 2 C). The eff  ect of IL-25 on Th2 cytokine expres-
sion was dose dependent and inhibited by anti–IL-25 antibody 
(Fig. 2 D). Our data indicate a novel function of IL-25 in di-
rectly promoting Th2 cell diff  erentiation.
IL-25 promotes Th2 cell differentiation in an IL-4– 
and STAT6-dependent manner
Th2 cell diff  erentiation is dependent on autocrine IL-4 pro-
duction by T cells. To understand the mechanism whereby 
IL-25 regulates Th2 cell diff  erentiation, we assessed cytokine 
gene expression during T cell diff  erentiation. Naive CD4+ 
T cells were activated with or without IL-25. On days 1, 2 and 
3 after stimulation, cytokine gene expression was analyzed by 
real-time RT-PCR. IL-25 up-regulated IL-4 and IL-5 gene 
expression while down-regulating the expression of IFN-γ 
after 2 d of activation (Fig. 3 A). The induction of IL-4 and 
other Th2 cytokines was increasingly pronounced by day 3 
of activation, suggesting that IL-25 may regulate early Th2 
cytokine gene expression. To determine whether IL-25–
  mediated Th2 cell diff  erentiation depends on early IL-4 
Figure 2.  IL-25 promotes Th2 cell differentiation in vitro. 
(A) mRNA expression of IL-17RB on freshly isolated naive T cells and in 
vitro–generated Th1 and Th2 cells was analyzed by RT-PCR. (B) Naive T cells 
were stimulated with anti-CD3, anti-CD28, and IL-2 in the presence of 
human IgG or recombinant IL-25. After 4 d, cells were restimulated with 
plate-bound anti-CD3 for 24 h, and cytokine production was measured by 
ELISA. *, P < 0.005. (C) Naive T cells were activated as described with or 
without anti–IFN-γ in the presence of human IgG or recombinant IL-25. 
After 5 d, cells were restimulated with PMA/ionomycin, and the expression 
of IL-4 and IFN-γ was analyzed. Numbers within the quadrants indicate 
the percentage of cells stained positive for each respective cytokine. (D) 
Naive T cells were purifi  ed and stimulated with anti-CD3, anti-CD28, anti–
IFN-γ, and IL-2 in the presence of different concentrations of IL-25 for 6 
d. 50 μg/ml anti–IL-25 mAb was added to the culture containing 
IL-25 at 2 μg/ml. The amounts of cytokines were measured by ELISA. 
Data are presented as mean values + SD and are representative of at 
least two independent experiments. HPRT, hypoxanthine-guanine 
phosphoribosyltransferase.JEM VOL. 204, July 9, 2007  1513
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  production by T cells, we performed the Th cell diff  eren-
tiation experiment in the presence of neutralizing anti–IL-4 
  antibody. Anti–IL-4 completely abolished IL-4 and IL-5 
production and moderately inhibited IL-13 induction, as de-
termined by ELISA and real-time RT-PCR analysis on day 4 
after activation (Fig. 3, B and C). Similarly, although IL-25 
promoted Th2 cell diff  erentiation in wild-type T cells, IL-25 
was not able to induce IL-4 and IL-5 production by IL-4–
  defi  cient cells (Fig. 3 D), though residual expression of IL-13 
was still detectable. Thus, IL-25–mediated Th2 cell diff  eren-
tiation is dependent on IL-4.
STAT proteins are selectively required in cytokine-
mediated Th cell lineage diff  erentiation. Because IL-25 pro-
motion of Th2 cell diff  erentiation is dependent on IL-4, we 
tested whether STAT6 is involved. Naive CD4+ T cells were 
activated with anti-CD3 and anti-CD28 with or without 
  IL-25 or with IL-25 and anti–IL-4 neutralizing antibody for 
2 d and subjected them to a Western blot analysis of STAT3, 
STAT5, and STAT6 phosphorylation. IL-6, IL-2, and IL-4 
were included as the positive controls for STAT3, STAT5, 
and STAT6 phosphorylation, respectively. IL-25 treatment, 
although not aff  ecting STAT3 and STAT5 phosphorylation, 
enhanced that of STAT6 (Fig. 4 A). Because STAT6 phos-
phorylation was completely abolished by an anti–IL-4 antibody 
(Fig. 4 A), STAT6 is likely activated by IL-4. To further 
address the possibility that IL-25 directly phoshorylates 
STAT6 or enhances IL-4 signaling, naive Th cells isolated from 
IL-4–defi  cient mice were activated with anti-CD3 and CD28 
Figure 3.  IL-25 promotes Th2 cell differentiation in an IL-4-
  dependent manner. (A) Naive T cells were purifi  ed and stimulated with 
anti-CD3, anti-CD28, and IL-2 with or without IL-25. Cells were collected 
at the indicated time points for real-time PCR analysis. (B and C) Naive 
T cells were stimulated with anti-CD3, anti-CD28, and IL-2 with or without 
IL-25 or with the addition of anti–IL-4 mAb. After 4 d of culture, cells were 
washed and restimulated with anti-CD3 for 4 h to analyze the cytokine 
expression by real-time RT-PCR or for 24 h to measure the level of cytokine 
expression by ELISA. *, P < 0.05. (D) Naive T cells from IL-4–defi  cient mice 
were stimulated as described with or without IL-25 and restimulated to 
measure the level of cytokine expression by ELISA. Data are presented as 
mean values + SD and are representative of two experiments. *, P < 0.05.1514  IL-25 REGULATION OF ALLERGIC RESPONSES | Angkasekwinai et al. 
in the presence of diff  erent concentration of exogenous IL-4 
with or without IL-25. In the absence of endogenous IL-4 
expression, IL-25 did not activate or enhance IL-4–induced 
STAT6 phosphorylation (Fig. S2, available at http://www
.jem.org/cgi/content/full/jem.20061675/DC1), supporting 
IL-25–potentiated STAT6 phosphorylation by inducing in-
creased levels of early IL-4. Next, we further determined 
whether STAT6 is required for IL-25–mediated Th2 cell 
diff  erentiation. Wild-type or STAT6-defi  cient naive Th cells 
were diff  erentiated in the presence or absence of IL-25, as de-
scribed in the previous paragraph. Although IL-25 enhanced 
IL-4 and IL-5 production in wild-type Th cells, no Th2 cy-
tokine induction by IL-25 was observed in STAT6-defi  cient 
cells (Fig. 4 B). These data support the conclusion that the 
regulation of Th2 cell diff  erentiation by IL-25 is dependent 
on the IL-4–STAT6 signaling pathway.
IL-25 induces early IL-4 expression through JunB 
and NFATc1
Early IL-4 production, through STAT6, plays an important 
role in regulating the expression of GATA-3, a master regu-
lator of Th2 cell development. To examine the molecular 
mechanism whereby IL-25 regulates Th2 cell diff  erentiation, 
we assessed the expression of GATA-3. Naive T cells were 
activated in the absence or presence of IL-25. At day 2 after 
activation, T cells were analyzed for the mRNA expression 
of GATA-3 and T-bet by real-time PCR analysis. Although 
no change in the T-bet expression level was detected, consider-
able up-regulation of GATA-3 mRNA was observed upon 
IL-25 stimulation (Fig. 5 A). Similarly, GATA-3 protein ex-
pression was enhanced by IL-25 at this time point (Fig. 5 A). 
GATA-3 mRNA and protein expression was inhibited by 
anti–IL-4 antibody (Fig. 5 A). These results indicate a fun-
ction of IL-25 in GATA-3 regulation, which is dependent 
on IL-4.
To understand the mechanisms whereby IL-25 regulates 
early IL-4 production, we also measured the expression of 
additional transcription regulators. NFATc1 and JunB are 
important in controlling early IL-4 expression during Th2 
cell diff  erentiation (4). Interestingly, we found that the pro-
tein expression of NFATc1 and JunB was substantially in-
creased in the presence of IL-25, and this up-regulation could 
not be completely blocked by anti–IL-4 (Fig. 5 A). Our re-
sults suggest that IL-25 may regulate early IL-4 expression 
directly through potentiating the induction of NFATc1 and 
JunB, which leads to IL-4–dependent up- regulation of 
GATA-3 expression.
Regulation of effector Th2 cells by IL-25
Because IL17RB expression is restricted to Th2 cells, we 
next examined whether IL-25 plays an additional role in po-
larized Th2 cells. Naive T cells isolated from OT-II TCR 
transgenic mice were diff  erentiated into Th1 or Th2 cell 
lineages. After 5 d of polarization, Th1 and Th2 cells were 
restimulated with anti-CD3 in the absence or presence of 
IL-25. As shown by intracellular cytokine analysis of IL-4 and 
Figure 4.  IL-25 promotes Th2 cell differentiation in a STAT6-
dependent manner. (A) Naive T cells were purifi  ed and stimulated with 
anti-CD3 and anti-CD28 with or without IL-25. IL-4, IL-2, and IL-6 were 
included in the treatment as positive controls for STAT6, STAT5, and STAT3 
phosphorylation, respectively. Cells were collected at 48 h for Western 
blot analysis. (B) Purified naive T cells from STAT6-deficient and wild-
type mice (BALB/c) were stimulated with anti-CD3, anti-CD28, and IL-2 
with or without IL-25. After 5 d of culture, cells were restimulated with 
PMA/ionomycin to assess the levels of IL-4 and IL-5 and IFN-γ expression. 
Numbers in the quadrants/gates represent the percentage of cells stained 
positive for each respective cytokine. SSC, side scatter. JEM VOL. 204, July 9, 2007  1515
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IFN-γ expression, IL-25 treatment resulted in an increased 
number of IL-4–expressing Th2 cells while having no eff  ect 
on IFN-γ–secreting Th1 cells (Fig. 5 B). Consistently, IL-25 
also enhanced the production of IL-4 and IL-5 in Th2 cells 
generated from naive T cells isolated from C57BL/6 mice but 
not IFN-γ and TNF-α production in Th1 cells (Fig. 5 C). 
Thus, IL-25 functions not only by potentiating early IL-4 
production to promote Th2 cell diff  erentiation but also by 
enhancing the expansion and cytokine production of eff  ector 
Th2 cells.
In summary, we found that IL-25, up-regulated in lung 
epithelial cells exposed to allergens, functions to regulate pro-
allergic responses in vivo. More importantly, we discovered a 
direct function of IL-25 on Th cells in promoting Th2 cell 
diff  erentiation and enhancing Th2 cytokine production in 
polarized Th2 cells. We identifi  ed NFATc1 and JunB as the 
transcription factors directly regulated by IL-25 to increase 
early IL-4 production, which results in enhanced GATA-3 
expression and Th2 cell diff  erentiation. This action of IL-25 
resembles those of inducible T cell co-stimulator (22) and 
OX40 (23). As a result of polarized diff  erentiation, Th2 cells 
selectively express IL-17RB and respond to IL-25 for their 
expansion and cytokine production. All of these data support 
an important function of IL-25 in type II immunity; IL-25 
may serve as a therapeutic target for diseases such as allergic 
asthma. In addition, recent fi  ndings by Owyang et al. using a 
gut infection model indicated that IL-25 is required for limit-
ing type 1 infl  ammation (10). The mechanisms we identifi  ed 
in this report whereby IL-25 regulates type II responses may 
apply to nonallergic systems and may be benefi  cial in protect-
ing hosts from uncontrolled immune-mediated pathology.
MATERIALS AND METHODS
Generation of IL-25 recombinant protein and anti–IL-25 mAbs. 
Recombinant mouse IL-25–Ig protein was prepared as we previously re-
ported (24). Anti–IL-25 mAbs were generated as previously described (25).
Generation and analysis of IL-25 transgenic mice. Full-length 
cDNA encoding mouse IL-25 was cloned into the cc10 promoter construct 
Figure 5.  The function of IL-25 in early Th cell activation and in 
effector Th2 cells. (A) Naive T cells were stimulated with anti-CD3 and 
anti-CD28 with or without IL-25 or with the addition of anti–IL-4 antibody. 
Cells were collected at 72 h for real-time PCR or 48 h for Western blot 
analysis. (B) Purifi  ed naive T cells from transgenic OT-II mice were differen-
tiated into Th1 and Th2 cells. After 5 d of culture, cells were washed and 
restimulated with anti-CD3 with or without IL-25 for 3 d to assess the 
levels of IL-4 and IFN-γ expression by intracellular cytokine staining. The 
percentages in the fi  gure represent cells stained positive for each cytokine 
indicated. (C) Purifi  ed naive T cells from C57BL/6 mice were stimulated with 
anti-CD3 and anti-CD28 with the same treatment as in B. After 5 d of 
culture, Th1 and Th2 cells were washed and restimulated with anti-CD3 with 
or without IL-25 for 2 d to assess the levels of IL-4, IL-5, IFN-γ, and TNF-α 
expression by ELISA. Data are presented as mean values + SD. *, P < 0.05.1516  IL-25 REGULATION OF ALLERGIC RESPONSES | Angkasekwinai et al. 
(a gift from J. Elias, Yale University, New Haven, CT), as we previously did for 
the IL-17 transgenic mouse (12). The IL-25 transgene construct was micro-
injected into C57BL/6 mice at the Transgenic Mouse Facility at the Univer-
sity of Washington. Four IL-25 transgenic founders were obtained and bred 
with B6 mice. Two transgenic lines expressing high IL-25 mRNA levels 
were further characterized. The level of IL-25 expression was determined by 
RT-PCR and ELISA using an ELISA kit (R&D Systems). For histological 
analysis of IL-25 transgenic mice, 6–40-wk-old IL-25 transgenic mice or 
littermate controls were killed, and individual lungs were fi  xed in 10% buff  er 
formalin or frozen. Hematoxylin and eosin (H&E), Giemsa, and PAS stain-
ing were performed by Histology Consultation Services, Inc.
Lung epithelial cell culture. Mouse lung epithelial (MLE12) and human 
lung epithelial (A549) cell lines were obtained from American Type Culture 
Collection. Primary lung epithelial cells were isolated from C57BL/6 mice, 
as previously described (26), after depletion with anti-CD32/CD16 and anti-
CD45 antibodies (Miltenyi Biotec). Cells were treated with 200 ng/ml 
A. oryzae protease or ragweed. After 6 h of stimulation, cells were collected and 
lysed, and mRNA was extracted by using TRIzol reagent (Invitrogen).
Induction and analysis of an asthma model. C57BL/6 mice were in-
duced with airway infl  ammation by A. oryzae for six total challenges, as pre-
viously described (15). Anti–IL-25 or 100 μg of a control rat Ig was given 
intraperitoneally at the time of challenge. 24 h after the last challenge, 
mice were killed for analysis of BAL fl  uid. BAL cells were collected and 
  further subjected to diff  erential cell counts and fl  ow cytometry analysis by 
staining with mAb to CCR3 for eosinophils and CD4 (BD Biosciences). 
BAL fl  uid was measured for cytokines by ELISA. All animal studies were 
approved by the MD Anderson Cancer Center Institutional Animal Care 
and Use Committee.
Th cell diff  erentiation. Lymph nodes and spleens of various mice were 
FACS-sorted based on the CD4+CD62LhiCD44lo surface phenotypes 
(96–99% purity) and stimulated with 2 μg/ml of plate-bound anti-CD3 plus 
5 μg/ml of soluble anti-CD28 and 50 U/ml of human IL-2 in the presence 
of 2 μg/ml of human Ig or IL-25Ig or 500 ng/ml of human IL-25 (R&D 
Systems). After 4 d of restimulation, cells were washed and restimulated with 
2 μg/ml of plate-bound anti-CD3 for 24 h, and culture supernatants were 
collected and analyzed for cytokines by ELISA. Naive T cells from OT-II mice 
purifi  ed by FACS sorting were diff  erentiated into Th1 or Th2 cells, as we 
previously reported (27). After 5 d of stimulation, Th1 and Th2 cells were 
restimulated with 0.5 μg/ml anti-CD3 with or without IL-25 for an addi-
tional 3 d. For intracellular cytokine analysis, cells were restimulated with 
500 ng/ml ionomycin and 50 ng/ml PMA in the presence of GolgiStop (BD 
Biosciences) for 5 h. Cells were permeabilized with a Cytofi  x/Cytoperm kit 
(BD Biosciences) and analyzed for the expression of IFN-γ, IL-4, and IL-5.
RT-PCR analysis. Total RNA extracted using TRIzol reagent was used 
to generate cDNA using oligo-dT, random hexamers, and SuperScript RT 
II (Invitrogen). For quantitation of cytokine and transcription factor gene 
expression, cDNA samples were amplifi  ed in iQ SYBR Green Supermix (Bio-
Rad Laboratories). The primer pairs used for RT-PCR are shown in Table S1 
(available at http://www.jem.org/cgi/content/full/jem.20061675/DC1).
Immunoblot analysis. Cell lysates prepared as previously reported (22) were 
subjected to Western blot analysis with anti–phospho-STAT6 (Tyr641), anti–
phospho-STAT5 (Tyr694), anti–phospho-STAT3 (Tyr705), STAT3, STAT5a, 
and STAT6 antibodies (provided by K. Arima and E. Esashi, University of 
Texas MD Anderson Cancer Center, Houston, TX) and antiactin (Sigma-
Aldrich), anti–GATA-3, and anti-JunB (Santa Cruz Biotechnology, Inc.) anti-
bodies. The signal was detected with ECL reagent (Pierce Chemical Co.).
Statistical analysis. Data are presented as mean values + SD. Data were 
analyzed using the Student’s t test (n = 2 groups). P < 0.05 was consid-
ered signifi  cant.
Online supplemental material. Fig. S1 shows an analysis of IL-25 expres-
sion by real-time PCR and ELISA in transgenic mice and control littermates. 
Fig. S2 depicts increased STAT6 phosphorylation in IL-4– defi  cient T cells 
in response to exogenous IL-4 but not IL-25 treatment. Table S1 provides 
the primer pairs used for RT-PCR analysis. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20061675/DC1.
We thank Julie Duong, Smita Aggarwal, and Ying Wang for assistance; Dr. Jack Elias 
for the cc10 promoter construct; Dr. Kazuhiko Arima for Western blot reagents; and 
the entire Dong lab for their help and discussion.
Supported in part by National Institutes of Health grants (to C. Dong). 
P. Angkasekwinai received a fellowship from the Royal Thai government, Y.-J. Liu 
received a Senior Sandler Asthma Research Award, and C. Dong is a Cancer 
Research Institute Investigator, an American Lung Association Career Investigator, 
and a Trust Fellow of the MD Anderson Cancer Center.
The authors have no confl  icting fi  nancial interests.
Submitted: 7 August 2006
Accepted: 16 May 2007
R  E  F  E  R  E  N  C  E  S 
 1. Murphy, K.M. 1998. T lymphocyte diff  erentiation in the periphery. 
Curr. Opin. Immunol. 10:226–232.
 2.  Dong, C., and R.A. Flavell. 2000. Cell fate decision: T-helper 1 and 2 
subsets in immune responses. Arthritis Res. 2:179–188.
 3. Dong, C. 2006. Diversifi  cation of T-helper-cell lineages: fi  nding the 
family root of IL-17-producing cells. Nat. Rev. Immunol. 6:329–334.
  4.  Dong, C., and R.A. Flavell. 2000. Control of T helper cell diff  erentia-
tion—in search of master genes. Sci. STKE. 2000:PE1.
  5.  Hurst, S.D., T. Muchamuel, D.M. Gorman, J.M. Gilbert, T. Cliff  ord, S. 
Kwan, S. Menon, B. Seymour, C. Jackson, T.T. Kung, et al. 2002. New 
IL-17 family members promote Th1 or Th2 responses in the lung: in 
vivo function of the novel cytokine IL-25. J. Immunol. 169:443–453.
 6. Fort, M.M., J. Cheung, D. Yen, J. Li, S.M. Zurawski, S. Lo, S. 
Menon, T. Cliff  ord, B. Hunte, R. Lesley, et al. 2001. IL-25 induces 
IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 
15:985–995.
 7. Lee, J., W.H. Ho, M. Maruoka, R.T. Corpuz, D.T. Baldwin, J.S. 
Foster, A.D. Goddard, D.G. Yansura, R.L. Vandlen, W.I. Wood, and 
A.L. Gurney. 2001. IL-17E, a novel proinfl  ammatory ligand for the 
IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276:1660–1664.
 8.  Pan, G., D. French, W. Mao, M. Maruoka, P. Risser, J. Lee, J. Foster, 
S. Aggarwal, K. Nicholes, S. Guillet, et al. 2001. Forced expres-
sion of murine IL-17E induces growth retardation, jaundice, a Th2-
biased response, and multiorgan infl  ammation in mice. J. Immunol. 
167:6559–6567.
  9.  Kim, M.R., R. Manoukian, R. Yeh, S.M. Silbiger, D.M. Danilenko, 
S. Scully, J. Sun, M.L. DeRose, M. Stolina, D. Chang, et al. 2002. 
Transgenic overexpression of human IL-17E results in eosinophilia, 
B-lymphocyte hyperplasia, and altered antibody production. Blood. 
100:2330–2340.
10. Owyang, A.M., C. Zaph, E.H. Wilson, K.J. Guild, T. McClanahan, 
H.R. Miller, D.J. Cua, M. Goldschmidt, C.A. Hunter, R.A. Kastelein, 
and D. Artis. 2006. Interleukin 25 regulates type 2 cytokine-dependent 
immunity and limits chronic infl  ammation in the gastrointestinal tract. 
J. Exp. Med. 203:843–849.
11. Fallon, P.G., S.J. Ballantyne, N.E. Mangan, J.L. Barlow, A. Dasvarma, 
D.R. Hewett, A. McIlgorm, H.E. Jolin, and A.N. McKenzie. 2006. 
Identifi  cation of an interleukin (IL)-25–dependent cell population that 
provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. 
J. Exp. Med. 203:1105–1116.
12. Park, H., Z. Li, X.O. Yang, S.H. Chang, R. Nurieva, Y.H. Wang, 
Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct 
lineage of CD4 T cells regulates tissue infl  ammation by producing 
interleukin 17. Nat. Immunol. 6:1133–1141.
13. Zhu, Z., R.J. Homer, Z. Wang, Q. Chen, G.P. Geba, J. Wang, Y. 
Zhang, and J.A. Elias. 1999. Pulmonary expression of interleukin-13 
causes infl   ammation, mucus hypersecretion, subepithelial   fi  brosis, JEM VOL. 204, July 9, 2007  1517
BRIEF DEFINITIVE REPORT
physiologic abnormalities, and eotaxin production. J. Clin. Invest. 
103:779–788.
14.  Liu, Y.J. 2006. Thymic stromal lymphopoietin: master switch for aller-
gic infl  ammation. J. Exp. Med. 203:269–273.
15.  Kheradmand, F., A. Kiss, J. Xu, S.H. Lee, P.E. Kolattukudy, and D.B. 
Corry. 2002. A protease-activated pathway underlying Th cell type 2 
activation and allergic lung disease. J. Immunol. 169:5904–5911.
16. Corry, D.B., G. Grunig, H. Hadeiba, V.P. Kurup, M.L. Warnock, D. 
Sheppard, D.M. Rennick, and R.M. Locksley. 1998. Requirements for 
allergen-induced airway hyperreactivity in T and B cell-defi  cient mice. 
Mol. Med. 4:344–355.
17. Wynn, T.A. 2003. IL-13 eff  ector functions. Annu. Rev. Immunol. 
21:425–456.
18. Tamachi, T., Y. Maezawa, K. Ikeda, S. Kagami, M. Hatano, Y. Seto, 
A. Suto, K. Suzuki, N. Watanabe, Y. Saito, et al. 2006. IL-25 enhances 
allergic airway infl  ammation by amplifying a TH2 cell-dependent path-
way in mice. J. Allergy Clin. Immunol. 118:606–614.
19.  Wang, Y.H., T. Ito, B. Homey, N. Watanabe, R. Martin, C.J. Barnes, B.W. 
McIntyre, M. Gilliet, R. Kumar, Z. Yao, and Y.J. Liu. 2006. Maintenance 
and polarization of human TH2 central memory T cells by thymic stromal 
lymphopoietin-activated dendritic cells. Immunity. 24:827–838.
20. Chtanova, T., S.G. Tangye, R. Newton, N. Frank, M.R. Hodge, 
M.S. Rolph, and C.R. Mackay. 2004. T follicular helper cells express a 
distinctive transcriptional profi  le, refl  ecting their role as non-Th1/Th2 
eff  ector cells that provide help for B cells. J. Immunol. 173:68–78.
21. Bosco, A., K.L. McKenna, C.J. Devitt, M.J. Firth, P.D. Sly, and P.G. 
Holt. 2006. Identifi  cation of novel Th2-associated genes in T memory 
responses to allergens. J. Immunol. 176:4766–4777.
22.  Nurieva, R.I., J. Duong, H. Kishikawa, U. Dianzani, J.M. Rojo, I. Ho, 
R.A. Flavell, and C. Dong. 2003. Transcriptional regulation of th2 dif-
ferentiation by inducible costimulator. Immunity. 18:801–811.
23.  So, T., J. Song, K. Sugie, A. Altman, and M. Croft. 2006. Signals from 
OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 
lineage commitment. Proc. Natl. Acad. Sci. USA. 103:3740–3745.
24. Sun, M., S. Richards, D.V. Prasad, X.M. Mai, A. Rudensky, and C. 
Dong. 2002. Characterization of mouse and human B7-H3 genes. 
J. Immunol. 168:6294–6297.
25. Prasad, D.V., T. Nguyen, Z. Li, Y. Yang, J. Duong, Y. Wang, and 
C. Dong. 2004. Murine B7-H3 is a negative regulator of T cells. 
J. Immunol. 173:2500–2506.
26.  Wang, J., F. Gigliotti, S. Maggirwar, C. Johnston, J.N. Finkelstein, and 
T.W. Wright. 2005. Pneumocystis carinii activates the NF-kappaB signal-
ing pathway in alveolar epithelial cells. Infect. Immun. 73:2766–2777.
27.  Chung, Y., X. Yang, S.H. Chang, L. Ma, Q. Tian, and C. Dong. 2006. 
Expression and regulation of IL-22 in the IL-17-producing CD4+ 
T lymphocytes. Cell Res. 16:902–907.